Skip to content
MyStudyTimes.com
Provider Reviews

Enhance MD vs Telos Rx: Semaglutide and Tirzepatide Pricing Guide

Rate this post

The comparison Enhance MD vs Telos Rx comes down to introductory pricing, flat-rate dose policy, compound availability, and enrollment terms. Quick verdict: if lowest first-month cost for either compound is your priority, Enhance MD shows the lowest advertised entry prices; if you prefer an advertised “as low as” monthly price with explicit cancellation terms, Telos Rx presents that option.

See Enhance MD starting at $49 first month

Overview: pricing statements and clinician review

Both providers offer compounded semaglutide and tirzepatide prescribed only after review by a licensed clinician. The regulatory note for both is the same in the source: compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. That shared status is central to any direct comparison of Enhance MD vs Telos Rx.

Three distinctive differences between Enhance MD and Telos Rx

1) Advertised starting prices

Enhance MD advertises semaglutide from $49 and tirzepatide from $99 for the first month. Telos Rx advertises semaglutide as low as $99 per month and tirzepatide as low as $139 per month. Those starting-price statements are the clearest, supported pricing claims in each provider’s source material and are often decisive for cost-sensitive patients.

View Telos Rx pricing as low as $99

2) Pricing model and dose escalation

Enhance MD emphasizes flat-rate pricing: the same price at every dose with no fee escalation during titration and the lowest first-month price for both compounds. Telos Rx materials repeatedly note “as low as” pricing and state that your price depends on your plan; Telos Rx also highlights cancel anytime terms. The difference: Enhance MD highlights flat-rate stability once ongoing pricing is set; Telos Rx emphasizes variable pricing tied to approval and plan.

3) Transparency and enrollment caveats

Enhance MD cites concrete first-month numbers and calls out their 10,000+ patients treated figure in the source. Telos Rx warns readers to confirm eligibility, pharmacy, state coverage, and renewal terms before enrollment, and its source repeatedly notes pricing, eligibility, pharmacy, state coverage and renewal terms may change. That makes Telos Rx’s messaging more conditional in the captured evidence.

Side-by-side snapshot

Criteria Enhance MD Telos Rx
Semaglutide starting price Semaglutide from $49 first month Semaglutide as low as $99 per month
Tirzepatide starting price Tirzepatide from $99 first month Tirzepatide as low as $139 per month
Pricing model Flat-rate pricing: same price at every dose, no escalation “As low as” pricing; price depends on plan and approval
Enrollment and approval Clinician-directed review; treated 10,000+ patients Prescribed only after review by a US-licensed provider; confirm eligibility
Regulatory note Compounded medications are not FDA-approved Compounded medications are not FDA-approved

What the sources say about care and terms

Enhance MD presents clinician-directed metabolic care with both semaglutide and tirzepatide available on one platform and emphasizes a consistent price from first dose to last, plus metabolic lab testing every six months in captured materials. Telos Rx highlights that a US-licensed provider decides which molecule is right for you, notes that pay $0 if not approved language appears in captured text, and states cancel anytime, no penalties in its materials. Both sources stress clinician review and the compounded status of the medications.

Start Enhance MD enrollment from $49

Safety, regulatory, and coverage notes

Both providers’ captured materials include the same regulatory qualifier: compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Telos Rx explicitly tells readers to confirm eligibility, pharmacy, state coverage and renewal terms before enrollment. Enhance MD notes clinician-directed prescribing and that treatment is available only when a licensed clinician determines it is medically appropriate.

Conclusion: which to choose

In short, Enhance MD vs Telos Rx is largely a choice between lower advertised first-month entry prices and a flat-rate messaging from Enhance MD versus Telos Rx’s “as low as” monthly pricing and conditional enrollment language. Both require clinician review and both offer compounded semaglutide and tirzepatide.

Check Telos Rx terms and eligibility

Compare Enhance MD options and pricing

Choose Enhance MD if…

  • You prioritize the lowest advertised first-month price: semaglutide from $49 and tirzepatide from $99 in the source.
  • You prefer a flat-rate pricing model that the source describes as the same price at every dose with no escalation.
  • You want access to both semaglutide and tirzepatide on one platform per the captured evidence.

Choose Telos Rx if…

  • You want an “as low as” monthly price and explicit cancel anytime language in the source.
  • You plan to confirm eligibility, pharmacy, state coverage and renewal terms before enrollment, as the source advises.

Ready to Compare GLP-1, NAD+, TRT Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

Leave a comment

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment.